Navigation Links
Sunrise Biotech Holding Limited Application For Admission to PLUS
Date:11/14/2007

BEIJING, Nov. 14 /Xinhua-PRNewswire/ -- The directors of Sunrise Biotech Holding Limited ("Sunrise" or the "Company"), a leading producer of organic mulberry-based products in China, are pleased to announce the Company has applied for the admission of its entire ordinary share capital for trading on the PLUS Market.

LISTING DETAILS

SECTOR CLASSIFICATION Biology Technology

PRINCIPLE ACTIVITIES The development and production of

mulberry tree-based organic

products -- namely: mulberry tea,

mulberry leaf powder and tablets

for use in food additives and

herbal remedies, and mulberry

leaf powder and granules for use

as animal fodder

OVERVIEW

Sunrise Biotech Holding Limited is a recently formed holding company incorporated in Jersey that owns 100% of the total share capital of Beijing Sunrise, which, in turn, owns 100% of the total share capital of Hebei Sunrise (together "the Group"). Founded January 2005, Beijing Sunrise develops and produces organic mulberry-based products from three locations in the Yongledian Region of Beijing. Hebei Sunrise, founded May 2005, operates from one location in the Hebei region of China. Currently, the Company's product range is focused on the production of mulberry tea, mulberry leaf powder and tablets for use in food additives and herbal remedies, and mulberry leaf powder and granules for use as animal fodder.

The Group's production base currently consists of over 3,100 acres of leased land, which produces an annual mulberry leaf capacity of 24,000 tons. In 2006, the Company generated net profits of GBP1,432,72.

ANTICIPATED ADMISSION

Yonghu Li, chairman of Sunrise Holding Ltd., commented: "The Admission on the PLUS market represents a significant development for the Company which has the potential to improve its corporate governance and raise funds for its future development."

Fortunes Capital, one of the renowned financial advisory firms, has led in the listing process. Steve Wayne, president of Fortunes Capital (China), said: "Sunrise Biotech is a unique company with great potential for growth, which is one of few companies to advocate mulberry-based food and healthcare solutions. Sunrise is establishing its leading stand in this market segmentation of China biotech Industry."

Trading in the Company's shares on PLUS is expected before the end of December 2007. An announcement will be loaded onto the PLUS official website in the near future.


'/>"/>
SOURCE Sunrise Biotech Holding Limited
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
3. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
4. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
5. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
10. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
11. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... ... Implant Systems announced today that the two-level components for the Revolution™ Spinal System were ... components expand the capabilities of the system and allow Revolution™ to be utilized for ... company has seen significant sales growth in 1Q 2016, and the system is currently ...
(Date:4/28/2016)... , April 28, 2016 ... reports the Company,s CEO  was featured in an ... Enter When VCs Fear To Tread: http://www.lifescienceleader.com/doc/accelerators-enter-when-vcs-fear-to-tread-0001 ... magazine is an essential business journal ... from emerging biotechs to Big Pharmas. Their content ...
(Date:4/28/2016)... York, NY (PRWEB) , ... April 28, 2016 ... ... QuickSTAT has made significant investments in recruiting top industry experts, and expanding its ... Platform, which provides industry-leading tools for clients to manage their clinical trial projects. ...
(Date:4/27/2016)... ... , ... Shimadzu Scientific Instruments (SSI) will be showcasing a ... and Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products for potency, ... by booth 1021 to learn how Shimadzu’s instruments can help improve QA/QC testing, ...
Breaking Biology Technology:
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
(Date:3/15/2016)... 2016 Yissum Research Development Company of ... of the Hebrew University, announced today the formation of ... of various human biological indicators. Neteera Technologies has completed ... private investors. ... of electromagnetic emissions from sweat ducts, enables reliable and ...
(Date:3/10/2016)... , March 10, 2016 ... new market research report "Identity and Access Management Market ... Audit, Compliance, and Governance), by Organization Size, by Deployment, ... 2020", published by MarketsandMarkets, The market is estimated to ... 12.78 Billion by 2020, at a Compound Annual Growth ...
Breaking Biology News(10 mins):